Le Lézard22h
Appili Therapeutics Announces Submission of U.S. Federal Government Funding Proposals and Provides Corporate and Aditxt Transaction Update
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced that, the Company ...
News-Medical.Net on MSN3h
Researchers explore H. pylori treatment policies in the Asia-Pacific region
Helicobacter pylori bacteria is considered to be the main cause of gastric cancer, with the infection rate particularly high ...
Exploring Helicobacter pylori treatment practices in the Asia-Pacific region
Helicobacter pylori bacteria is considered to be the main cause of gastric cancer, with the infection rate particularly high ...
Le Lézard22h
RedHill Biopharma to Submit FDA-Approved Talicia® for UK Marketing Authorisation
RedHill Biopharma Ltd. ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced its plan to submit a UK Marketing Authorisation Application (MAA) for Talicia for treatment ...
RedHill Biopharma Ltd.: RedHill Biopharma to Submit FDA-Approved Talicia for UK Marketing Authorisation
RedHill plans to submit UK MAA1 for Talicia for H. pylori infection, using MHRA's2 new fast-track approval process, referencing FDA approval, with potential UK approval ...